Hubei Saichuang

Hubei Saichuang is a life sciences group based in Wuhan, China, that integrates biotechnology research and development with the distribution of advanced laboratory technologies. The group's primary innovative division, Hubei Saichuang Biotech, is a leader in the field of exosome-based therapeutics and diagnostics, utilizing a proprietary platform for vesicle engineering and targeted drug delivery. Their therapeutic pipeline is currently focused on addressing unmet needs in oncology and chronic liver diseases, such as liver fibrosis. In addition to its R&D efforts, the group operates a significant distribution business providing high-end analytical instruments and reagents to the Chinese scientific community. Saichuang has established GMP-compliant manufacturing facilities to support the clinical translation of its exosome candidates. The company is a prominent member of the Wuhan Optics Valley biotech cluster and maintains strong collaborations with leading academic institutions.